The American Cancer Society Cancer Action Network recently honored Olney resident Polly Sulcer with its Capitol Dome Volunteer of the Year award at the U.S. Capitol in Washington, D.C.
The American Cancer Society Cancer Action Network (ACS CAN) released a publication today to illustrate health disparities across the cancer continuum and discuss public policy strategies to address those disparities. Cancer Disparities: A Chartbook illustrates the scope of cancer disparities that exist in the United States.
TRENTON, NJ – October 17, 2018 – Both candidates for the 11th Congressional District seat in New Jersey have publicly stated their positions on how, if elected, they would work to make cancer a national priority.
On Friday, October 26, ACS CAN will host its annual policy forum in Oregon. This year's event focuses on the pressing issues surrounding the cost of breast cancer across different types of insurance.
HARRISBURG, PA – October 16, 2018 – The Pennsylvania Senate is scheduled to vote on HB 1800 this week.
The American Cancer Society Cancer Action Network (ACS CAN), the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, urges voters to check ‘yes’ on Avon’s Ballot Issue 2B. It would raise taxes on cigarettes by $3 per pack and increase the price of other tobacco products, including e-cigarettes, by 40 percent.
American Cancer Society Cancer Action Network (ACS CAN) released a voter guide that details where the two major candidates for North Dakota’s United States Senate seat stand on three important federal policy issues that affect cancer prevention and treatment.
Today the U.S. Senate rejected a resolution under the Congressional Review Act that would have prevented the extension and expansion of short-term limited duration health insurance plans (STLD) as allowed under a new rule from the Departments of Health and Human Services (HHS) and Treasury.
Nearly 150 people attended the American Cancer Society Cancer Action Network’s ninth annual Cancer Research Breakfast at the North Carolina Museum of History. The event provided a forum for leaders to discuss current barriers to therapeutic clinical trials and the efforts needed to overcome them.
